A detailed history of Williams Jones Wealth Management, Llc. transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Williams Jones Wealth Management, Llc. holds 40,000 shares of NWBO stock, worth $17,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,000
Previous 44,000 9.09%
Holding current value
$17,200
Previous $30,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$0.48 - $0.69 $1,920 - $2,760
-4,000 Reduced 9.09%
40,000 $20,000
Q4 2022

Feb 14, 2023

BUY
$0.66 - $1.15 $3,300 - $5,750
5,000 Added 12.82%
44,000 $34,000
Q1 2021

May 17, 2021

SELL
$1.32 - $1.63 $14,520 - $17,930
-11,000 Reduced 22.0%
39,000 $58,000
Q3 2019

Nov 14, 2019

BUY
$0.2 - $0.28 $10,000 - $14,000
50,000 New
50,000 $12,000

Others Institutions Holding NWBO

About NORTHWEST BIOTHERAPEUTICS INC


  • Ticker NWBO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,037,230,016
  • Market Cap $446M
  • Description
  • Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...
More about NWBO
Track This Portfolio

Track Williams Jones Wealth Management, Llc. Portfolio

Follow Williams Jones Wealth Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Williams Jones Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Williams Jones Wealth Management, Llc. with notifications on news.